Scynexis (SCYX) Net Cash Flow (2013 - 2026)
Scynexis (SCYX) reported Net Cash Flow of $15.4 million for Q1 2026, up 269.2% on a YoY basis from $4.2 million in Q1 2025, and up 138.5% quarter-over-quarter from $6.5 million in Q4 2025.
Scynexis (SCYX) Net Cash Flow (2013 - 2026) Analysis & Trends
Scynexis has reported Net Cash Flow for 14 years, with the latest figure at $15.4 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow rose 269.2% year-over-year to $15.4 million; the trailing twelve-month figure through Mar 2026 stood at $29.4 million (up 202.93% YoY), and the FY2025 full-year result was $4.9 million, up 126.96% from the prior year.
- Net Cash Flow for Q1 2026 stood at $15.4 million, up from $6.5 million in the prior quarter.
- The five-year high for Net Cash Flow was $31.4 million in Q2 2023, with the low at -$50.1 million in Q3 2022.
- Historically, Net Cash Flow has averaged -$4.0 million across 5 years, with a median of -$9.1 million in 2025.
- Annual changes were most pronounced in 2022 — Net Cash Flow sank 800.39% — and 2026, when it jumped 269.2%.
- Scynexis' Net Cash Flow stood at -$22.8 million in 2022, then jumped by 56.06% to -$10.0 million in 2023, then retreated by 26.51% to -$12.7 million in 2024, then soared by 150.97% to $6.5 million in 2025, then jumped by 138.5% to $15.4 million in 2026.
- The last three Net Cash Flow figures came in at $15.4 million (Q1 2026), $6.5 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | 15.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.41 Mn |
| Mar 31, 2026 | 15.41 Mn |
| Dec 31, 2025 | 6.46 Mn |
| Dec 31, 2025 | 6.46 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | -9.11 Mn |
| Mar 31, 2025 | -9.11 Mn |
| Dec 31, 2024 | -12.68 Mn |
| Dec 31, 2024 | -12.68 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | -9.49 Mn |
| Jun 30, 2024 | -9.49 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | -10.02 Mn |
| Dec 31, 2023 | -10.02 Mn |